Recent advances in understanding antiphospholipid syndrome

Area of Science:

• Immunology
• Rheumatology
• Hematology

Background:

• Antiphospholipid syndrome (APS), or Hughes Syndrome, is an autoimmune disorder.
• It is defined by thrombosis and/or pregnancy complications with specific antiphospholipid antibodies.
• Current diagnostic criteria require lupus anticoagulant, anticardiolipin, or anti-b2 glycoprotein I antibodies.

Purpose of the Study:

• To investigate the relevance of additional antiphospholipid antibody specificities in APS.
• To evaluate the diagnostic value of novel autoantibodies in patients with thrombosis or pregnancy morbidity.

Main Methods:

• Review of existing diagnostic criteria for APS.
• Exploration of emerging autoantibodies targeting coagulation proteins and their complexes.
• Assessment of the clinical utility of new antiphospholipid antibody tests.

Main Results:

• Standard criteria for APS diagnosis are well-established.
• Several other autoantibodies (e.g., anti-prothrombin, anti-phosphatidylserine/prothrombin) are implicated in APS.
• The diagnostic value of these new specificities is under active investigation.

Conclusions:

• Beyond established markers, novel antiphospholipid antibodies may contribute to APS pathogenesis.
• Further research is needed to validate new antibody tests for improved APS identification.
• Expanding diagnostic panels could enhance the detection of APS in at-risk individuals.